RECRUITING

Assessing the Effects of Photobiomodulation on Clinical Recovery From Concussion in Adolescents

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to compare effects of Photobiomodulation therapy (PBMt) to standard of care in adolescent athletes at risk for delayed recovery from subacute sports concussion, to substantiate the impact of subacute PBMt over time on functional and structural connectivity of the brain using advanced MRI sequences and to correlate the psychological and behavioral outcomes to neuroimaging findings

Official Title

Assessing the Effects of Photobiomodulation on Clinical Recovery From Concussion in Adolescents

Quick Facts

Study Start:2024-04-17
Study Completion:2026-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06239818

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * current participants in a school- or club-sponsored sport (contact or non-contact)
  2. * access to wireless internet service at home
  3. * diagnosis of sports-related concussion (SRC) (according to consensus diagnostic criteria) by a licensed healthcare provider,3-7 days from the concussive injury at the time of enrolment
  4. * considered at-risk for protracted recovery based on Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) performance and symptom reporting on the Post-Concussion Symptom Scale (PCSS)
  1. * acute neurologic deterioration to a Glasgow Coma Scale score less than 13
  2. * neurosurgical intervention
  3. * abnormal CT scan
  4. * concomitant extracranial injury worse than mild
  5. * pre-injury conditions which confound effects of SRC (e.g., epilepsy, schizophrenia, bipolar illness, mental deficiency, hospitalization for TBI)
  6. * substance dependence
  7. * inability to speak fluent English
  8. * Individuals who are taking benzodiazepines, anti-convulsants, mood stabilizers, stimulants, opioids, sleep aids, or other neuropsychiatric medications

Contacts and Locations

Study Contact

Summer Ott, PsyD
CONTACT
(713) 486-3435
Summer.D.Ott@uth.tmc.edu
Sukhnandan Cheema
CONTACT
(713) 486-3553
Sukhnandan.Cheema@uth.tmc.edu

Principal Investigator

Summer Ott, PsyD
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston

Study Locations (Sites)

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Summer Ott, PsyD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-17
Study Completion Date2026-04-01

Study Record Updates

Study Start Date2024-04-17
Study Completion Date2026-04-01

Terms related to this study

Additional Relevant MeSH Terms

  • Sports-related Concussion